Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 04 Mar 2024 07:00 CET |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease | 20103010 Biotechnology | Corporate life |
| 08 Jan 2024 07:00 CET |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 | 20103010 Biotechnology | Meetings / events |
| 06 Dec 2023 07:00 CET |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress | 20103010 Biotechnology | Corporate life |
| 28 Nov 2023 07:00 CET |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 | 20103010 Biotechnology | Other subject |
| 07 Nov 2023 07:00 CET |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference | 20103010 Biotechnology | Meetings / events |